Mike Venters

Co-Founder and CEO

Mr. Mike Venters is the co-founder and owner of Cameron Pharmaceuticals LLC and Pharma Trading Partners, serving as the managing partner of Business Development and Operations. Prior to co-founding Cameron, Mr. Venters was President of Macoven Pharmaceuticals as well as Vice President of Business Development at Pernix Therapeutics. In 2009, Mr. McMahon and Mr. Venters founded Macoven Pharmaceuticals, a generic pharmaceutical company, that was acquired by Pernix Therapeutics in September 2010. Under the management of Mr. McMahon and Mr. Venters, Macoven doubled its revenue each year for the first three years following its launch. Since starting his career at Dura Pharmaceuticals in 1991, he has held positions in many functional areas with ever-increasing responsibility. Mr. Venters has experience in both brand and generic pharmaceuticals, as well as multiple therapeutic areas. Cameron pharmaceuticals will be the third generic company that the pair has built from inception. Mr Venters was a founding member of Cornerstone Therapeutics where he served in the roles of Branded National Sales Director, Director of Corporate Development, Director of Trade Relations, as well as VP of Corporate Development and Sales for Aristos Pharmaceuticals which was a generic subsidiary of Cornerstone Therapeutics. Mr. Venters earned a Bachelor of Science in Marketing at the University of Kentucky.